[ATX] YoY Annual Result on 31-Mar-2021 [#FY]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#FY]
Profit Trend
YoY- -2.79%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Annual Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 4,453 1,189 1,983 1,534 34 50 580 40.41%
PBT -8,941 -7,391 -5,628 -3,815 -2,254 -1,920 -4,298 12.97%
Tax -4,438 -1,148 -1,983 -1,534 -34 -50 -0 -
NP -4,503 -6,242 -3,644 -2,281 -2,219 -1,870 -4,298 0.77%
Tax Rate - - - - - - - -
Total Cost 8,956 7,432 5,628 3,815 2,254 1,920 4,878 10.64%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -101.14 -524.80 -183.74 -148.75 -6,484.57 -3,704.79 -740.59 -28.21%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.02 -0.03 -0.03 -0.02 -0.04 -0.04 -0.17 -29.97%
EPS Diluted -0.02 -0.03 -0.03 -0.02 -0.04 -0.04 -0.17 -29.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.